The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Kometova V.V.

National Medical Research Center for Obstetrics, Gynecology and Perinatology named after academician V.I. Kulakov

Mikhaleva L.M.

Avtsyn Research Institute of Human Morphology of Petrovsky National Research Centre of Surgery

Rodionov V.V.

National Medical Research Center for Obstetrics, Gynecology and Perinatology named after academician V.I. Kulakov

Rodionova M.V.

National Medical Research Center for Obstetrics, Gynecology and Perinatology named after academician V.I. Kulakov

NDRG1 protein expression in breast cancer samples, relationship with lymph nodes metastasis

Authors:

Kometova V.V., Mikhaleva L.M., Rodionov V.V., Rodionova M.V.

More about the authors

Read: 1261 times


To cite this article:

Kometova VV, Mikhaleva LM, Rodionov VV, Rodionova MV. NDRG1 protein expression in breast cancer samples, relationship with lymph nodes metastasis. Russian Journal of Archive of Pathology. 2024;86(6):36‑42. (In Russ.)
https://doi.org/10.17116/patol20248606136

Recommended articles:
Capsular contracture after reco­nstructive plastic surgery for breast cancer. P.A. Herzen Journal of Onco­logy. 2024;(6):78-83

References:

  1. Villodre ES, Nguyen APN, Debeb BG. NDRGs in breast cancer: a review and in silico analysis. Cancers (Basel). 2024;16(7):1342. https://doi.org/10.3390/cancers16071342
  2. Vaes N, Schonkeren SL, Brosens E, Koch A, McCann CJ, Thapar N, Hofstra RMW, van Engeland M, Melotte V. A combined literature and in silico analysis enlightens the role of the NDRG family in the gut. Biochim Biophys Acta Gen Subj. 2018;1862(10):2140-2151. https://doi.org/10.1016/j.bbagen.2018.07.004
  3. Schonkeren SL, Massen M, van der Horst R, Koch A, Vaes N, Melotte V. Nervous NDRGs: the N-myc downstream-regulated gene family in the central and peripheral nervous system. Neurogenetics. 2019;20(4):173-186.  https://doi.org/10.1007/s10048-019-00587-0
  4. Ulrix W, Swinnen JV, Heyns W, Verhoeven G. The differentiation-related gene 1, Drg1, is markedly upregulated by androgens in LNCaP prostatic adenocarcinoma cells. FEBS Lett. 1999;455(1-2):23-26.  https://doi.org/10.1016/S0014-5793(99)00845-5
  5. Stein S, Thomas EK, Herzog B, Westfall MD, Rocheleau JV, Jackson RS 2nd, Wang M, Liang P. NDRG1 is necessary for p53-dependent apoptosis. J Biol Chem. 2004;279(47):48930-48940. https://doi.org/10.1074/jbc.m400386200
  6. Liu N, Wang L, Liu X, Yang Q, Zhang J, Zhang W, Wu Y, Shen L, Zhang Y, Yang A, et al. Promoter methylation, mutation, and genomic deletion are involved in the decreased NDRG2 expression levels in several cancer cell lines. Biochem Biophys Res Commun. 2007;358(1):164-169.  https://doi.org/10.1016/j.bbrc.2007.04.089
  7. Croessmann S, Wong HY, Zabransky DJ, Chu D, Mendonca J, Sharma A, Mohseni M, Rosen DM, Scharpf RB, Cidado J, et al. NDRG1 links p53 with proliferation-mediated centrosome homeostasis and genome stability. Proc Natl Acad Sci U S A. 2015;112(37):11583-11588. https://doi.org/10.1073/pnas.1503683112
  8. Cangul H. Hypoxia upregulates the expression of the NDRG1 gene leading to its overexpression in various human cancers. BMC Genet. 2004;5:27.  https://doi.org/10.1186/1471-2156-5-27
  9. López-Tejada A, Griñán-Lisón C, González-González A, Cara FE, Luque RJ, Rosa-Garrido C, Blaya-Cánovas JL, Navarro-Ocón A, Valenzuela-Torres M, Parra-López M, et al. TGFβ governs the pleiotropic activity of NDRG1 in triple-negative breast cancer progression. Int J Biol Sci. 2023;19(1):204-224.  https://doi.org/10.7150/ijbs.78738
  10. Bae DH, Jansson PJ, Huang ML, Kovacevic Z, Kalinowski D, Lee CS, Sahni S, Richardson DR. The role of NDRG1 in the pathology and potential treatment of human cancers. J Clin Pathol. 2013;66(11):911-917.  https://doi.org/10.1136/jclinpath-2013-201692
  11. Chen Z, Zhang D, Yue F, Zheng M, Kovacevic Z, Richardson DR. The iron chelators Dp44mT and DFO inhibit TGF-β-induced epithelial-mesenchymal transition via up-regulation of N-Myc downstream-regulated gene 1 (NDRG1). J Biol Chem. 2012;287(21):17016-17028. https://doi.org/10.1074/jbc.M112.350470
  12. Godbole M, Togar T, Patel K, Dharavath B, Yadav N, Janjuha S, Gardi N, Tiwary K, Terwadkar P, Desai S, et al. Up-regulation of the kinase gene SGK1 by progesterone activates the AP-1-NDRG1 axis in both PR-positive and -negative breast cancer cells. J Biol Chem. 2018;293(50):19263-19276. https://doi.org/10.1074/jbc.RA118.002894
  13. Mao XY, Fan CF, Wei J, Liu C, Zheng HC, Yao F, Jin F. Increased N-myc downstream-regulated gene 1 expression is associated with breast atypia-to-carcinoma progression. Tumour Biol. 2011;32(6):1271-1276. https://doi.org/10.1007/s13277-011-0232-z
  14. Nagai MA, Gerhard R, Fregnani JH, Nonogaki S, Rierger RB, Netto MM, Soares FA. Prognostic value of NDRG1 and SPARC protein expression in breast cancer patients. Breast Cancer Res Treat. 2011;126(1):1-14.  https://doi.org/10.1007/s10549-010-0867-2
  15. Villodre ES, Gong Y, Hu X, Huo L, Yoon EC, Ueno NT, Woodward WA, Tripathy D, Song J, Debeb BG. NDRG1 expression is an independent prognostic factor in inflammatory breast cancer. Cancers (Basel). 2020;12(12):3711. https://doi.org/10.3390/cancers12123711
  16. Villodre ES, Hu X, Eckhardt BL, Larson R, Huo L, Yoon EC, Gong Y, Song J, Liu S, Ueno NT, et al. NDRG1 in aggressive breast cancer progression and brain metastasis. J Natl Cancer Inst. 2022;114(4):579-591.  https://doi.org/10.1093/jnci/djab222
  17. de Nonneville A, Finetti P, Mamessier E, Bertucci F. RE: NDRG1 in aggressive breast cancer progression and brain metastasis. J Natl Cancer Inst. 2022;114(7):1046-1047. https://doi.org/10.1093/jnci/djac031
  18. Sommer EM, Dry H, Cross D, Guichard S, Davies BR, Alessi DR. Elevated SGK1 predicts resistance of breast cancer cells to Akt inhibitors. Biochem J. 2013;452(3):499-508.  https://doi.org/10.1042/BJ20130342
  19. Kotepui K, Kotepui M, Majima HJ, Tangpong J. Association between NDRG1 protein expression and aggressive features of breast cancer: a systematic review and meta-analysis. BMC Cancer. 2023;23(1):1003. https://doi.org/10.1186/s12885-023-11517-7

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.